newsfilter
← Latest News
GlobeNewswire·

Alimera Announces Submission of Marketing Authorization Application in Switzerland for ILUVIEN®

ATLANTA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal